Viewing Study NCT00086112


Ignite Creation Date: 2025-12-26 @ 10:43 PM
Ignite Modification Date: 2026-03-05 @ 9:42 AM
Study NCT ID: NCT00086112
Status: COMPLETED
Last Update Posted: 2012-07-23
First Post: 2004-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anxiety Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anxiety View
None antipsychotic View